D Lapuente, J Fuchs, J Willar, A Vieira Antão… - Nature …, 2021 - nature.com
… Concomitantly, the intranasal boost strategies lead to complete protection against a SARS-CoV-2 infection in mice. Our data thus suggest that mucosal boosterimmunizations after …
H Gruell, K Vanshylla, P Tober-Lau, D Hillus… - Nature medicine, 2022 - nature.com
… However, mRNA boosterimmunizations in vaccinated and … This study demonstrates that boosterimmunizations can … immune response to SARS-CoV-2, and boosterimmunizations (that …
… Here we observed that an mRNA vaccine booster in … of homologous mRNA-vaccine or a boost of mRNA vaccine after infection, … Our study demonstrates that mRNA vaccine booster in …
A Sattler, E Schrezenmeier, UA Weber… - The Journal of …, 2021 - Am Soc Clin Investig
… boosterimmunization after 21 days. Blood samples for cellular analysis were collected on day 8 ± 1 after boost… day 0 and day 8 ± 1 after boost. Sera of 24 KTx patients were additionally …
… of protection against SARS-CoV-2 in humans remain to be determined, we speculate that the substantially enhanced immune responses after boostimmunization will lead to improved …
… -prime mucosal boost is an effective strategy for protecting against SARS-CoV-2 infection and … prime - mucosal boost was superior to parenteral only immunization for protecting against …
… The objective of a booster dose is to restore vaccine effectiveness from the immune … A boosterimmunization offers re-exposure to the immunizing antigen after initial immunization. It is …
L Stamatatos, J Czartoski, YH Wan, LJ Homad, V Rubin… - Science, 2021 - science.org
… , but a single immunizationboosted neutralizing titers against all variants and SARS-CoV-1 by up … targeting the receptor binding domain and was not boosted by a second immunization. …
J Liu, K Xu, M Xing, Y Zhuo, J Guo, M Du, Q Wang… - Cell Discovery, 2021 - nature.com
… SARS-CoV-2 infection in mouse lungs. Strikingly, we found that heterologous prime-boost immunization … antibodies produced against the highly transmissible SARS-CoV-2 variants B.…